Skip to main content
Log in

ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review

  • Case Report
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Leukocyte chemotactic factor-2 amyloidosis (ALECT2) is a recently described subtype of amyloidosis. IgG4-related disease is a rare fibroinflammatory condition characterized by dense interstitial lymphoplasmacytic infiltrates and fibrosis. Membranous nephropathy and diabetic nephropathy are common causes of nephrotic syndrome. Here we report a 49-year-old Hispanic male patient with diabetes mellitus who presented with jaundice and pruritus. IgG4-related autoimmune pancreatitis was diagnosed through laboratory workup and ampulla biopsy. He subsequently presented with marked lower extremity edema and nephrotic syndrome. Kidney biopsy showed severe interstitial IgG4-positive plasma cell-rich inflammatory infiltrates and interstitial storiform fibrosis. Immunofluorescence microscopy revealed diffuse and finely granular glomerular capillary wall staining for IgG and the glomeruli were negative for anti-phospholipase A2 receptor. Congo red stain was positive for birefringent deposits in the interstitium, arteriolar walls, and glomeruli. Electron microscopy demonstrated subepithelial immune complex-type electron-dense deposits, thickening of glomerular basement membranes (GBM), and randomly oriented fibrils in the mesangium, GBM, and interstitium. Mass spectrometry identified a peptide profile consistent with ALECT2 amyloidosis. This is the first report of a case with concurrence of ALECT2 amyloidosis, IgG4-related disease involving the kidney, membranous nephropathy, and early diabetic kidney injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Data availability

The clinical data (with the patient’s identifiable information deleted), and original pathology images of conventional light microscopy, immunohistochemical stains, immunofluorescence, special stains, electron microscopy, and mass spectrometry report can be accessed upon request.

References

  1. Mann BK, Bhandohal JS, Cobos E et al (2022) LECT-2 amyloidosis: what do we know? J Investig Med 70(2):348–353. https://doi.org/10.1136/jim-2021-002149

    Article  PubMed  Google Scholar 

  2. Larsen CP, Beggs ML, Wilson JD et al (2016) Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico. Amyloid 23(2):119–123. https://doi.org/10.3109/13506129.2016.1145110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Nasr SH, Dogan D, Larsen CP (2015) Leukocyte cell-derived chemotaxin 2–associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol 10(11):2084–2093. https://doi.org/10.2215/CJN.12551214

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Said SM, Sanjeev S, Valeri AM et al (2014) Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int 86(2):370–377. https://doi.org/10.1038/ki.2013.558

    Article  CAS  PubMed  Google Scholar 

  5. Larsen CP, Kossmann RJ, Beggs ML et al (2014) Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int 86(2):378–382. https://doi.org/10.1038/ki.2014.11

    Article  CAS  PubMed  Google Scholar 

  6. Herrera GA (2020) Renal amyloidosis with emphasis on the diagnostic role of electron microscopy. Ultrastruct Pathol 44(4–6):325–341. https://doi.org/10.1080/01913123.2020.1844355

    Article  CAS  PubMed  Google Scholar 

  7. Benson MD (2010) LECT2 amyloidosis. Kidney Int 77(9):757–759. https://doi.org/10.1038/ki.2010.18

    Article  CAS  PubMed  Google Scholar 

  8. Rezk T, Gilbertson JA, Rowczenio D et al (2018) Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis. Nephrol Dial Transplant 33(2):241–247. https://doi.org/10.1093/NDT/GFW375

    Article  CAS  PubMed  Google Scholar 

  9. Larsen CP, Ismail W, Kurtin PJ et al (2016) Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians. Mod Pathol 29(4):416–420. https://doi.org/10.1038/MODPATHOL.2016.29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Li D-Y, Liu D, Wang S-X et al (2020) Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients. Amyloid 27(2):134–141. https://doi.org/10.1080/13506129.2020.1722097

    Article  CAS  PubMed  Google Scholar 

  11. Eletta O, Ali M, Grieff A et al (2021) Clinically occult amyloidosis derived from leukocyte chemotactic factor 2 (ALECT 2) with cardiac involvement complicating renal transplantation: case report and literature review. Cardiovasc Pathol 55:107375. https://doi.org/10.1016/j.carpath.2021.107375

    Article  CAS  PubMed  Google Scholar 

  12. Kameoka Y, Yamagoe S, Hatano Y, Kasama T, Suzuki K (2000) Val58Ile polymorphism of the neutrophil chemoattractant LECT2 and rheumatoid arthritis in the Japanese population. Arthritis Rheum 43(6):1419–1420. https://doi.org/10.1002/1529-0131(200006)43:6%3c1419::AID-ANR28%3e3.0.CO;2-I

    Article  CAS  PubMed  Google Scholar 

  13. Xu J, Wang X, Weng Q, Feng X, Pan X (2023) First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis. BMC Nephrol 24(1):283. https://doi.org/10.1186/s12882-023-03331-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Raissian Y, Nasr SH, Larsen CP et al (2011) Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22(7):1343. https://doi.org/10.1681/ASN.2011010062

    Article  PubMed  PubMed Central  Google Scholar 

  15. Horita S, Fujii H, Mizushima I et al (2019) A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer: imaging features of IgG4-related kidney disease. Mod Rheumatol 29(3):542–546. https://doi.org/10.1080/14397595.2016.1245238

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Fredrik Hans Skarstedt for his great assistance in preparing the figures.

Funding

The authors received no financial support for the work on this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shunhua Guo.

Ethics declarations

Conflict of interests

The authors declare no competing interests with respect to the research, authorship, and publication of this article.

Ethical approval

Not applicable, because this article includes a report of one case.

Human and animal rights

The present study complies with the guidelines for human studies. This study does not contain any studies with animals.

Informed consent to participate

The authors declare that they have obtained consent for publication from the patient reported in this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shaheen, M., Bharat, A., Friedman, A.N. et al. ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review. J Nephrol (2024). https://doi.org/10.1007/s40620-024-01924-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40620-024-01924-9

Keywords

Navigation